GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alzinova AB (OSTO:ALZ) » Definitions » EV-to-Revenue

Alzinova AB (OSTO:ALZ) EV-to-Revenue : 1,562.89 (As of Jun. 26, 2025)


View and export this data going back to 2015. Start your Free Trial

What is Alzinova AB EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Alzinova AB's enterprise value is kr154.73 Mil. Alzinova AB's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 was kr0.10 Mil. Therefore, Alzinova AB's EV-to-Revenue for today is 1,562.89.

The historical rank and industry rank for Alzinova AB's EV-to-Revenue or its related term are showing as below:

OSTO:ALZ' s EV-to-Revenue Range Over the Past 10 Years
Min: 92.02   Med: 577.12   Max: 9318.28
Current: 1562.89

During the past 9 years, the highest EV-to-Revenue of Alzinova AB was 9318.28. The lowest was 92.02. And the median was 577.12.

OSTO:ALZ's EV-to-Revenue is ranked worse than
96.08% of 995 companies
in the Biotechnology industry
Industry Median: 7.63 vs OSTO:ALZ: 1562.89

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2025-06-26), Alzinova AB's stock price is kr1.624. Alzinova AB's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2025 was kr0.00. Therefore, Alzinova AB's PS Ratio for today is 1,624.00.


Alzinova AB EV-to-Revenue Historical Data

The historical data trend for Alzinova AB's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alzinova AB EV-to-Revenue Chart

Alzinova AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only - - - - -

Alzinova AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 230.66 205.13 977.73 - 2,161.32

Competitive Comparison of Alzinova AB's EV-to-Revenue

For the Biotechnology subindustry, Alzinova AB's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alzinova AB's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Alzinova AB's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Alzinova AB's EV-to-Revenue falls into.


;
;

Alzinova AB EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Alzinova AB's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=154.726/0.099
=1,562.89

Alzinova AB's current Enterprise Value is kr154.73 Mil.
Alzinova AB's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.10 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Alzinova AB  (OSTO:ALZ) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Alzinova AB's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=1.624/0.001
=1,624.00

Alzinova AB's share price for today is kr1.624.
Alzinova AB's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Alzinova AB EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Alzinova AB's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Alzinova AB Business Description

Traded in Other Exchanges
Address
Pepparedsleden 1, Molndal, SWE, SE-431 83
Alzinova AB is a Swedish biotechnology company engaged in the discovery and development of therapeutics for the treatment of Alzheimer's disease. The company is engaged in the development of a specific oligomer-directed vaccine (ALZ-101), and ALZ-201 which is a monoclonal antibody that is specific for the toxic AB oligomers. The products of the company are in the clinical and preclinical stages of development as a therapeutic vaccine for the treatment of Alzheimer's.

Alzinova AB Headlines

No Headlines